DIA’s Annual Canadian Meeting: Evolutions in Risk Thinking

6 - 7 November 2012, Ottawa, Canada


Event summary

Rethinking and Redesigning Traditional Approaches during Changes in the Industry

Event Code:
12019



Speaker and commitee information

Program Co-Chairs
Neerja Goyal
Director, Regulatory Strategy and Policy
GlaxoSmithKline, Inc Canada
Paul Litowitz
A/Senior Advisor, DGO
Therapeutic Products Directorate, HPFB
Health Canada
Program Committee
Sandra Alderdice
Unit Head
Office of Regulatory Affairs, BGTD
Health Canada
Karen Feltmate
President
Redstone Health Group, Inc.
Alice Hui
Manager
Regulatory Project Management Division, TPD
Health Canada
Chanez Kebache
Drug Safety Surveillance Specialist
Covidien
Andrew Storey
Senior Vice President
Quality and Regulatory Affairs
Cangene Corporation

Other information

Call for Abstracts
All abstracts are due by April 23, 2012

Attendees may visit the tabletop exhibits during the event and receptions
Contact Jeff Korn, Worldwide Exhibits Associate
Phone +1.215.442.6184
Fax +1.215.442.6199,
Email Jeff.Korn@diahome.org,

Event contact information

  • Enterprise Drive, 19044, United States of America

Venue

  • Ottawa Marriott
  • Ottawa
  • K1P5R7
  • Canada


Organised by

DIA

Search
 
Include Online events
 
Select date range
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type